Hardy W. Chan
Präsident bei ScinoPharm (Kunshan) Biochemical Technology Co., Ltd.
Aktive Positionen von Hardy W. Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| National Cheng Kung University | Corporate Officer/Principal | - | - |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | Präsident | 09.11.2010 | - |
Karriereverlauf von Hardy W. Chan
Ehemalige bekannte Positionen von Hardy W. Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Tanvex BioPharma USA, Inc. | Vorstandsvorsitzender | - | - |
| Syntex Corp. | Corporate Officer/Principal | - | - |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Direktor/Vorstandsmitglied | 12.08.2010 | - |
| SCINOPHARM TAIWAN, LTD. | Gründer | 09.11.2010 | - |
Ausbildung von Hardy W. Chan
| University of Wisconsin | Doctorate Degree |
Statistik
International
| Taiwan | 4 |
| Vereinigte Staaten | 4 |
| China | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCINOPHARM TAIWAN, LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Syntex Corp. | Health Technology |
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | |
| Tanvex BioPharma USA, Inc. |
- Börse
- Insiders
- Hardy W. Chan
- Erfahrung
